On September 5, 2025, Ashley Cordova, the CEO of $NVCR, was estimated to have bought 81,550 shares for around $996,859. This information was identified through recent SEC filings and led to an approximate 22.9% increase in her holdings of this stock class, bringing her total to 437,569 shares.
$NVCR Insider Trading Activities
$NVCR insiders have conducted trading in the market 16 times over the past six months, with four of those being purchases and the remaining 12 as sales.
Here’s a summary of recent insider trading activities for $NVCR:
- Ashley Cordova (CEO) purchased 81,550 shares for an estimated total of $996,859.
- Frank X Leonard (EVP, President of NovoCure Oncology) completed three purchases and three sales, selling about 30,196 shares for $528,412.
- Christoph Blackman (CFO) acquired approximately 20,000 shares for an estimated $231,800 without any sales.
- W Anthony Vernon sold around 999 shares valued at $17,329.
- Timothy J Scannell sold about 999 shares for $17,299.
- Gabriel Leon also sold 999 shares, receiving $17,297.
- David Hung sold 999 shares for about $17,279.
- Allyson J Ocean sold 999 shares, valued at $17,269.
- Christine Stafford sold 999 shares for roughly $17,258.
- Jeryl L Hilleman sold 999 shares, valued at $17,246.
- Martin J. Madden sold 999 shares for around $17,175.
- Mukund Paravasthu (COO) sold 592 shares for an estimated $10,604.
For more updates on insider transactions, you can visit Quiver Quantitative’s Insider Trading Dashboard.
$NVCR Hedge Fund Activities
In the most recent quarter, 129 institutional investors increased their holdings in $NVCR, while 138 reduced their positions.
Some notable movements include:
- International Capital Investors exited completely, offloading 8,945,166 shares, which was a 100% reduction worth $159,223,954.
- Soleus Capital Management added 1,382,888 shares, a 25.0% increase valued at $24,615,406.
- Capital World Investors increased their position by 1,167,319 shares, a 22.4% growth worth $20,778,278.
- BlackRock, Inc. added 1,086,692 shares, representing an 8.3% increase valued at $19,343,117.
- American Century Companies Inc dramatically raised their position by 959,079 shares, a staggering 1354.7% increase worth $17,071,606.
- Deerfield Management Company, LP increased holdings by 825,119 shares, with notable growth.
- T. Rowe Price Investment Management, Inc. added 718,055 shares, also with significant increases.
To keep track of hedge fund portfolios, check out Quiver Quantitative’s Institutional Holdings Dashboard.
$NVCR Analyst Evaluation
Recent reports from Wall Street analysts on $NVCR have largely been positive, with one firm issuing a buy rating and none providing a sell rating.
A recent analyst rating includes:
- Piper Sandler announced an “overweight” rating on June 27, 2025.
More details on analyst ratings and price targets for $NVCR can be found on Quiver Quantitative’s $NVCR forecast page.
$NVCR Price Target
Several analysts have set recent price targets for $NVCR. Over the past six months, five analysts have provided targets, with a median value of $28.0.
Here are some of the latest price targets:
- Wells Fargo’s Larry Biegelsen targeted $14.5 on July 25, 2025.
- Kevin Degita from Radenburg Tarman set a target of $30.0 on July 8, 2025.
- Piper Sandler’s Jason Bednar targeted $34.0 on June 27, 2025.
- David Nierengarten from Wedbush aimed for $27.0 on April 16, 2025.
- Jessica Fai of JP Morgan set a target of $28.0 on April 10, 2025.
This article does not constitute financial advice. Please refer to the Quiver Quantitative Disclaimer for further information.
